The single amino acid change of R516K enables efficient generation of vesicular stomatitis virus-based Crimean-Congo hemorrhagic fever reporter virus
Xue MaiD, Yanlong Ma, Ziqiao WangiD, Fei Feng, Yutong HaniD, Xinran SuniD, Liushuai Li, Zhichao GaoiD, Manli WangiD, Rong ZhangiD
Abstract
Crimean-Congo hemorrhagic fever virus (CCHFV) is a medically important tick-borne virus, causing severe hemorrhagic diseases in humans. There is no approved vaccines and therapeutics for CCHFV infection. The study of CCHFV authentic virus requires biosafety level 3 facilities, hindering the research and development of antivirals. Here we report the generation of a recombinant vesicular stomatitis virus (VSV) bearing both CCHFV glycoprotein precursor (GPC) and EGFP reporter (rVSV-CCHFV-GFP). We also find that the acquisition of an unexpected single R516K mutation in the GPC protein enables the packaging of high-titer pseudotyped particles. The replication-competent rVSV-CCHFV-GFP reporter virus resembles the entry properties of authentic virus and allows for rapid assessment of susceptible cell lines, neutralizing antibodies, and host entry factors such as heparan sulfate in fluorescence-based assays. This study provides valuable strategy for packaging of high-titer CCHFV pseudovirus, and the tool generated here can be served for the identification and evaluation of countermeasures against the cell entry of CCHFV.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 9.13
- Field percentile
- top 1%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A single-dose recombinant rVSVΔG-CCHFV-GPC vaccine protects nonhuman primates against heterologous Crimean-Congo hemorrhagic fever virus challenge
Robert W. Cross, Kevin Melody, … Thomas W. Geisbert·bioRxiv·Oct 22, 2026
- Finding the Goldilocks zone: Modulating glycoprotein cleavage and fusogenicity optimizes the efficacy of a candidate Crimean-Congo hemorrhagic fever virus vaccine
Jacob L. Berrigan, Stephanie R. Monticelli, … Kartik Chandran·mBioPeer-reviewed·Oct 29, 2026
- A Low Containment CCHFV Entry Screening Platform Identifies Compounds with Antiviral Activity against Authentic CCHFV
Nallely Espinoza, Sophie N. Spector, … Pardis Christine Sabeti·bioRxiv·Aug 30, 2026
- Dual-Antigen CCHFV Vaccine Induces Neutralizing Immunity and Protection Against Lethal Challenge
Jingyi Yan, Lara Sweetapple, … Gustaf Ahlén·bioRxiv·Oct 13, 2026
- Engineering, structure, and immunogenicity of a Crimean-Congo hemorrhagic fever virus pre-fusion heterotrimeric glycoprotein complex
Elizabeth McFadden, Stephanie R. Monticelli, … Jason S. McLellan·CellPeer-reviewed·Dec 18, 2024
- Complete Protection Against Lethal Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Challenge in Mice Afforded by Immunization with Modified mRNA Encoding the Nucleocapsid Protein (NP) Alone
Sercan Keskin, Shaikh Terkıs Islam Pavel, … Mehmet Ziya Doymaz·bioRxiv·Apr 21, 2025